# Dense案例人工核对

按claim ID排序，每个重点分组取前几条；这不是代表性随机抽样。
保持原始标签和主评分不变，在人工记录中说明疑点。

## 命中标注证据，标签不一致

### claim 3

1,000 genomes project enables mapping of genetic sequence variation consisting of rare variants with larger penetrance effects than common variants.

- 标准标签：SUPPORT
- Dense预测：NOT_ENOUGH_INFO
- 自报依据：insufficient_information
- 引用了完整金标准rationale：False
- 自动核对提示：[]

模型解释：

The claim conflates two distinct ideas: that the 1,000 Genomes Project enables mapping of genetic sequence variation, and that rare variants have larger penetrance effects than common variants. None of the supplied abstracts mention the 1,000 Genomes Project at all, so the first part of the claim is unsupported by the provided evidence. Regarding the second part, the abstracts discuss the rare versus common variant debate (e.g., doc 2739854 notes divergence of opinion over whether variance is hidden as rare variants of large effect or common variants of small effect, and doc 23389795 contrasts common and rare variant hypotheses), but they do not establish that rare variants have larger penetrance effects than common variants as a settled fact. The abstracts present this as an open question rather than a demonstrated conclusion, and none specifically ties this to the 1,000 Genomes Project. Therefore there is insufficient basis to decide the claim.

其他条件：

- oracle_cited：NOT_ENOUGH_INFO；与标签一致=False；依据=insufficient_information
- retrieved_bm25：NOT_ENOUGH_INFO；与标签一致=False；依据=insufficient_information
- retrieved_dense：NOT_ENOUGH_INFO；与标签一致=False；依据=insufficient_information
- retrieved_hybrid：NOT_ENOUGH_INFO；与标签一致=False；依据=insufficient_information
- no_evidence：NOT_ENOUGH_INFO；与标签一致=False；依据=insufficient_information
- distractor_dense：NOT_ENOUGH_INFO；与标签一致=False；依据=insufficient_information

模型引用句：

无有效引用句。

金标准rationale（与模型输入分开列出）：

- 文档14717500：Rare Variants Create Synthetic Genome-Wide Associations；进入Dense上下文=True
  - 句2：We propose as an alternative explanation that variants much less common than the associated one may create "synthetic associations" by occurring, stochastically, more often in association with one of the alleles at the common site versus the other allele.
  - 句5：We show that they are not only possible, but inevitable, and that under simple but reasonable genetic models, they are likely to account for or contribute to many of the recently identified signals reported in genome-wide association studies.
  - 句7：In conclusion, uncommon or rare genetic variants can easily create synthetic associations that are credited to common variants, and this possibility requires careful consideration in the interpretation and follow up of GWAS signals.

Dense提供的完整摘要：

#### 文档 2739854：Rare and common variants: twenty arguments

[0] Genome-wide association studies have greatly improved our understanding of the genetic basis of disease risk.

[1] The fact that they tend not to identify more than a fraction of the specific causal loci has led to divergence of opinion over whether most of the variance is hidden as numerous rare variants of large effect or as common variants of very small effect.

[2] Here I review 20 arguments for and against each of these models of the genetic basis of complex traits and conclude that both classes of effect can be readily reconciled.

#### 文档 19058822：A fine-scale map of recombination rates and hotspots across the human genome.

[0] Genetic maps, which document the way in which recombination rates vary over a genome, are an essential tool for many genetic analyses.

[1] We present a high-resolution genetic map of the human genome, based on statistical analyses of genetic variation data, and identify more than 25,000 recombination hotspots, together with motifs and sequence contexts that play a role in hotspot activity.

[2] Differences between the behavior of recombination rates over large (megabase) and small (kilobase) scales lead us to suggest a two-stage model for recombination in which hotspots are stochastic features, within a framework in which large-scale rates are constrained.

#### 文档 23389795：Common and rare variants in multifactorial susceptibility to common diseases

[0] Here, we give a historical overview of the search for genetic variants that influence the susceptibility of an individual to a chronic disease, from RA Fisher's seminal work to the current excitement of whole-genome association studies (WGAS).

[1] We then discuss the concepts behind the identification of common variants as disease causal factors and contrast them to the basic ideas that underlie the rare variant hypothesis.

[2] The identification of rare variants involves the careful selection of candidate genes to examine, the availability of highly efficient resequencing techniques and the appropriate assessment of the functional consequences of the implicated variant.

[3] We believe that this strategy can be successfully applied at present in order to unravel the contribution of rare variants to the multifactorial inheritance of common diseases, which could lead to the implementation of much needed preventative screening schemes.

#### 文档 32181055：The role of regulatory variation in complex traits and disease

[0] We are in a phase of unprecedented progress in identifying genetic loci that cause variation in traits ranging from growth and fitness in simple organisms to disease in humans.

[1] However, a mechanistic understanding of how these loci influence traits is lacking for the majority of loci.

[2] Studies of the genetics of gene expression have emerged as a key tool for linking DNA sequence variation to phenotypes.

[3] Here, we review recent insights into the molecular nature of regulatory variants and describe their influence on the transcriptome and the proteome.

[4] We discuss conceptual advances from studies in model organisms and present examples of complete chains of causality that link individual polymorphisms to changes in gene expression, which in turn result in physiological changes and, ultimately, disease risk.

#### 文档 14717500：Rare Variants Create Synthetic Genome-Wide Associations

[0] Genome-wide association studies (GWAS) have now identified at least 2,000 common variants that appear associated with common diseases or related traits (http://www.genome.gov/gwastudies), hundreds of which have been convincingly replicated.

[1] It is generally thought that the associated markers reflect the effect of a nearby common (minor allele frequency >0.05) causal site, which is associated with the marker, leading to extensive resequencing efforts to find causal sites.

[2] We propose as an alternative explanation that variants much less common than the associated one may create "synthetic associations" by occurring, stochastically, more often in association with one of the alleles at the common site versus the other allele.

[3] Although synthetic associations are an obvious theoretical possibility, they have never been systematically explored as a possible explanation for GWAS findings.

[4] Here, we use simple computer simulations to show the conditions under which such synthetic associations will arise and how they may be recognized.

[5] We show that they are not only possible, but inevitable, and that under simple but reasonable genetic models, they are likely to account for or contribute to many of the recently identified signals reported in genome-wide association studies.

[6] We also illustrate the behavior of synthetic associations in real datasets by showing that rare causal mutations responsible for both hearing loss and sickle cell anemia create genome-wide significant synthetic associations, in the latter case extending over a 2.5-Mb interval encompassing scores of "blocks" of associated variants.

[7] In conclusion, uncommon or rare genetic variants can easily create synthetic associations that are credited to common variants, and this possibility requires careful consideration in the interpretation and follow up of GWAS signals.

人工核对记录：

- 引用是否支持模型结论：无引用，不适用；模型关于证据覆盖不足的解释具有一定依据。
- 是否存在疑似标注问题：存在论断与标注证据覆盖范围不一致的疑点，待复核。
- 错误类型：命中标注文档但标签不一致；可能涉及证据覆盖不足或标注歧义，不能直接归为模型理解错误。
- 判断理由：论断同时涉及1,000 Genomes Project、罕见变异及其相对外显率效应。
  金标准文档14717500的摘要主要讨论罕见变异造成合成关联，
  未明确提及1,000 Genomes Project，也未直接建立论断所述的完整比较关系。
  因此，当前摘要和标注证据不足以清楚支持完整论断。
  保留原始SUPPORT标签及评分，并将该案例记录为待复核。

### claim 48

A total of 1,000 people in the UK are asymptomatic carriers of vCJD infection.

- 标准标签：CONTRADICT
- Dense预测：NOT_ENOUGH_INFO
- 自报依据：insufficient_information
- 引用了完整金标准rationale：False
- 自动核对提示：[]

模型解释：

The claim asserts a specific number (1,000) of asymptomatic vCJD carriers in the UK. The most relevant abstract (13734012) reports a prevalence of abnormal prion protein in appendix samples of 493 per million (95% CI 282-801), which would correspond to roughly 30,000 carriers in a UK population of ~60 million, not 1,000. However, this estimate is for abnormal PrP prevalence, not confirmed asymptomatic vCJD infection, and the abstract does not state a figure of 1,000. None of the supplied abstracts provide a basis to confirm or refute the specific number of 1,000 asymptomatic carriers, so the evidence is insufficient to decide.

其他条件：

- oracle_cited：NOT_ENOUGH_INFO；与标签一致=False；依据=insufficient_information
- retrieved_bm25：NOT_ENOUGH_INFO；与标签一致=False；依据=insufficient_information
- retrieved_dense：NOT_ENOUGH_INFO；与标签一致=False；依据=insufficient_information
- retrieved_hybrid：NOT_ENOUGH_INFO；与标签一致=False；依据=insufficient_information
- no_evidence：NOT_ENOUGH_INFO；与标签一致=False；依据=insufficient_information
- distractor_dense：NOT_ENOUGH_INFO；与标签一致=False；依据=insufficient_information

模型引用句：

无有效引用句。

金标准rationale（与模型输入分开列出）：

- 文档13734012：Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey；进入Dense上下文=True
  - 句4：RESULTS Of the 32,441 appendix samples 16 were positive for abnormal PrP, indicating an overall prevalence of 493 per million population (95% confidence interval 282 to 801 per million).

Dense提供的完整摘要：

#### 文档 11349166：Lack of evidence of transfusion transmission of Creutzfeldt-Jakob disease in a US surveillance study.

[0] BACKGROUND Since 2004, several reported transfusion transmissions of variant Creutzfeldt-Jakob disease (vCJD) in the United Kingdom have reawakened concerns about the possible risk of similar transmissions of nonvariant or classic forms of CJD.   

[1] STUDY DESIGN AND METHODS Patients with a CJD diagnosis and a history of donating blood were reported to the study coordinator.

[2] Through review of blood distribution and hospital records, the recipients of blood components from these donors were identified.

[3] We then determined each recipient's vital status and, if deceased, the cause(s) of death identified by matching the recipient's personal identifiers with the Centers for Disease Control and Prevention's National Death Index database.

[4] We conducted such searches after recipients were enrolled in this study and annually thereafter for those who remained alive.    

[5] RESULTS The study included a total of 36 blood donors who subsequently developed CJD and 436 recipients.

[6] Through 2006, 91 of these recipients were still alive, 329 were deceased, and 16 were lost to follow-up.

[7] After transfusion, these three groups had survived a total of 2096.0 person-years.

[8] A total of 144 recipients survived 5 years or longer after transfusion and 68 of them had received blood donated 60 or fewer months before the onset of CJD in the donor.

[9] We identified no recipient with CJD.    

[10] CONCLUSIONS The current results of this large, ongoing lookback study show no evidence of transfusion transmission of CJD.

[11] They reinforce the conclusion that the risk, if any, of transfusion transmission of prion disease by CJD donors is significantly lower than the comparable risk of such transmission by vCJD donors.

#### 文档 29955650：Study of infectious intestinal disease in England: rates in the community, presenting to general practice, and reported to national surveillance. The Infectious Intestinal Disease Study Executive.

[0] OBJECTIVE To establish the incidence and aetiology of infectious intestinal disease in the community and presenting to general practitioners.

[1] Comparison with incidence and aetiology of cases reaching national laboratory based surveillance.    

[2] DESIGN Population based community cohort incidence study, general practice based incidence studies, and case linkage to national laboratory surveillance.    

[3] SETTING 70 general practices throughout England.    

[4] PARTICIPANTS 459 975 patients served by the practices.

[5] Community surveillance of 9776 randomly selected patients.    

[6] MAIN OUTCOME MEASURES Incidence of infectious intestinal disease in community and reported to general practice.    

[7] RESULTS 781 cases were identified in the community cohort, giving an incidence of 19.4/100 person years (95% confidence interval 18.1 to 20.8).

[8] 8770 cases presented to general practice (3.3/100 person years (2.94 to 3.75)).

[9] One case was reported to national surveillance for every 1.4 laboratory identifications, 6.2 stools sent for laboratory investigation, 23 cases presenting to general practice, and 136 community cases.

[10] The ratio of cases in the community to cases reaching national surveillance was lower for bacterial pathogens (salmonella 3.2:1, campylobacter 7.6:1) than for viruses (rotavirus 35:1, small round structured viruses 1562:1).

[11] There were many cases for which no organism was identified.    

[12] CONCLUSIONS Infectious intestinal disease occurs in 1 in 5 people each year, of whom 1 in 6 presents to a general practitioner.

[13] The proportion of cases not recorded by national laboratory surveillance is large and varies widely by microorganism.

[14] Ways of supplementing the national laboratory surveillance system for infectious intestinal diseases should be considered.

#### 文档 27063470：Sporadic Creutzfeldt-Jakob disease in the United Kingdom: analysis of epidemiological surveillance data for 1970-96.

[0] OBJECTIVE To identify changes in the occurrence of Creutzfeldt-Jakob disease that might be related to the epidemic of bovine spongiform encephalopathy.    

[1] DESIGN Epidemiological surveillance of the United Kingdom population for Creutzfeldt-Jakob disease based on (a) referral of suspected cases by neurologists, neuropathologists, and neurophysiologists and (b) death certificates.    

[2] SETTING England and Wales during 1970-84, and whole of the United Kingdom during 1985-96.   

[3] SUBJECTS All 662 patients identified as sporadic cases of Creutzfeldt-Jakob disease.    

[4] MAIN OUTCOME MEASURES Age distribution of patients, age specific time trends of disease, occupational exposure to cattle, potential exposure to causative agent of bovine spongiform encephalopathy.    

[5] RESULTS During 1970-96 there was an increase in the number of sporadic cases of Creutzfeldt-Jakob disease recorded yearly in England and Wales.

[6] The greatest increase was among people aged over 70.

[7] There was a statistically significant excess of cases among dairy farm workers and their spouses and among people at increased risk of contact with live cattle infected with bovine spongiform encephalopathy.

[8] During 1994-6 there were six deaths from sporadic Creutzfeldt-Jakob disease in the United Kingdom in patients aged under 30.    

[9] CONCLUSIONS The increase in the incidence of sporadic Creutzfeldt-Jakob disease and the high incidence in dairy farmers in the United Kingdom may be unrelated to bovine spongiform encephalopathy.

[10] The most striking change in the pattern of Creutzfeldt-Jakob disease in the United Kingdom after the epidemic of bovine spongiform encephalopathy is provided by the incidence in a group of exceptionally young patients with a consistent and unusual neuropathological profile.

[11] The outcome of mouse transmission studies and the future incidence of the disease in the United Kingdom and elsewhere, will be important in judging whether the agent causing bovine spongiform encephalopathy has infected humans.

#### 文档 13734012：Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey

[0] OBJECTIVES To carry out a further survey of archived appendix samples to understand better the differences between existing estimates of the prevalence of subclinical infection with prions after the bovine spongiform encephalopathy epizootic and to see whether a broader birth cohort was affected, and to understand better the implications for the management of blood and blood products and for the handling of surgical instruments.    

[1] DESIGN Irreversibly unlinked and anonymised large scale survey of archived appendix samples.    

[2] SETTING Archived appendix samples from the pathology departments of 41 UK hospitals participating in the earlier survey, and additional hospitals in regions with lower levels of participation in that survey.   

[3] SAMPLE 32,441 archived appendix samples fixed in formalin and embedded in paraffin and tested for the presence of abnormal prion protein (PrP).    

[4] RESULTS Of the 32,441 appendix samples 16 were positive for abnormal PrP, indicating an overall prevalence of 493 per million population (95% confidence interval 282 to 801 per million).

[5] The prevalence in those born in 1941-60 (733 per million, 269 to 1596 per million) did not differ significantly from those born between 1961 and 1985 (412 per million, 198 to 758 per million) and was similar in both sexes and across the three broad geographical areas sampled.

[6] Genetic testing of the positive specimens for the genotype at PRNP codon 129 revealed a high proportion that were valine homozygous compared with the frequency in the normal population, and in stark contrast with confirmed clinical cases of vCJD, all of which were methionine homozygous at PRNP codon 129.    

[7] CONCLUSIONS This study corroborates previous studies and suggests a high prevalence of infection with abnormal PrP, indicating vCJD carrier status in the population compared with the 177 vCJD cases to date.

[8] These findings have important implications for the management of blood and blood products and for the handling of surgical instruments.

#### 文档 5850219：Prevalence, risk factors, and uptake of interventions for sexually transmitted infections in Britain: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal)

[0] BACKGROUND Population-based estimates of prevalence, risk distribution, and intervention uptake inform delivery of control programmes for sexually transmitted infections (STIs).

[1] We undertook the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3) after implementation of national sexual health strategies, and describe the epidemiology of four STIs in Britain (England, Scotland, and Wales) and the uptake of interventions.    

[2] METHODS Between Sept 6, 2010 and Aug 31, 2012

[3] , we did a probability sample survey of 15,162 women and men aged 16-74 years in Britain.

[4] Participants were interviewed with computer-assisted face-to-face and self-completion questionnaires.

[5] Urine from a sample of participants aged 16-44 years who reported at least one sexual partner over the lifetime was tested for the presence of Chlamydia trachomatis, type-specific human papillomavirus (HPV), Neisseria gonorrhoeae, and HIV antibody.

[6] We describe age-specific and sex-specific prevalences of infection and intervention uptake, in relation to demographic and behavioural factors, and explore changes since Natsal-1 (1990-91) and Natsal-2 (1999-2001).    

[7] FINDINGS Of 8047 eligible participants invited to provide a urine sample, 4828 (60%) agreed.

[8] We excluded 278 samples, leaving 4550 (94%) participants with STI test results.

[9] Chlamydia prevalence was 1·5% (95% CI 1·1-2·0) in women and 1·1% (0·7-1·6) in men.

[10] Prevalences in individuals aged 16-24 years were 3·1% (2·2-4·3) in women and 2·3% (1·5-3·4) in men.

[11] Area-level deprivation and higher numbers of partners, especially without use of condoms, were risk factors.

[12] However, 60·4% (45·5-73·7) of chlamydia in women and 43·3% (25·9-62·5) in men was in individuals who had had one partner in the past year.

[13] Among sexually active 16-24-year-olds, 54·2% (51·4-56·9) of women and 34·6% (31·8-37·4) of men reported testing for chlamydia in the past year, with testing higher in those with more partners.

[14] High-risk HPV was detected in 15·9% (14·4-17·5) of women, similar to in Natsal-2.

[15] Coverage of HPV catch-up vaccination was 61·5% (58·2-64·7).

[16] Prevalence of HPV types 16 and 18 in women aged 18-20 years was lower in Natsal-3 than Natsal-2 (5·8% [3·9-8·6] vs 11·3% [6·8-18·2]; age-adjusted odds ratio 0·44 [0·21-0·94]).

[17] Gonorrhoea (<0·1% prevalence in women and men) and HIV (0·1% prevalence in women and 0·2% in men) were uncommon and restricted to participants with recognised high-risk factors.

[18] Since Natsal-2, substantial increases were noted in attendance at sexual health clinics (from 6·7% to 21·4% in women and from 7·7% to 19·6% in men) and HIV testing (from 8·7% to 27·6% in women and from 9·2% to 16·9% in men) in the past 5 years.    

[19] INTERPRETATION STIs were distributed heterogeneously, requiring general and infection-specific interventions.

[20] Increases in testing and attendance at sexual health clinics, especially in people at highest risk, are encouraging.

[21] However, STIs persist both in individuals accessing and those not accessing services.

[22] Our findings provide empirical evidence to inform future sexual health interventions and services.    

[23] FUNDING Grants from the UK Medical Research Council and the Wellcome Trust, with support from the Economic and Social Research Council and the Department of Health.

人工核对记录：

- 引用是否支持模型结论：UNREVIEWED
- 是否存在疑似标注问题：UNREVIEWED
- 错误类型：UNREVIEWED
- 判断理由：

## 未命中标注证据，标签不一致

### claim 70

Activation of PPM1D suppresses p53 function.

- 标准标签：SUPPORT
- Dense预测：NOT_ENOUGH_INFO
- 自报依据：insufficient_information
- 引用了完整金标准rationale：False
- 自动核对提示：[]

模型解释：

None of the supplied abstracts mention PPM1D (Wip1) or its effect on p53 function. The abstracts discuss p53 regulation by MDM2/HDM2, autophagy, senescence, and apoptotic cell clearance, but provide no evidence about PPM1D activation suppressing p53. Therefore, the claim cannot be evaluated from the provided material.

其他条件：

- oracle_cited：SUPPORT；与标签一致=True；依据=provided_evidence
- retrieved_bm25：SUPPORT；与标签一致=True；依据=provided_evidence
- retrieved_dense：NOT_ENOUGH_INFO；与标签一致=False；依据=insufficient_information
- retrieved_hybrid：SUPPORT；与标签一致=True；依据=provided_evidence
- no_evidence：SUPPORT；与标签一致=True；依据=model_knowledge
- distractor_dense：NOT_ENOUGH_INFO；与标签一致=False；依据=insufficient_information

模型引用句：

无有效引用句。

金标准rationale（与模型输入分开列出）：

- 文档4414547：Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer；进入Dense上下文=False
  - 句5：Functional studies demonstrate that the mutations result in enhanced suppression of p53 in response to ionizing radiation exposure, suggesting that the mutant alleles encode hyperactive PPM1D isoforms.
- 文档5956380：Exome sequencing identifies somatic gain-of-function PPM1D mutations in brainstem gliomas；进入Dense上下文=False
  - 句5：PPM1D mutations were mutually exclusive with TP53 mutations in BSG and attenuated p53 activation in vitro.
  - 句6：PPM1D mutations were truncating alterations in exon 6 that enhanced the ability of PPM1D to suppress the activation of the DNA damage response checkpoint protein CHK2.

Dense提供的完整摘要：

#### 文档 11903247：Regulation of autophagy by cytoplasmic p53

[0] Multiple cellular stressors, including activation of the tumour suppressor p53, can stimulate autophagy.

[1] Here we show that deletion, depletion or inhibition of p53 can induce autophagy in human, mouse and nematode cells subjected to knockout, knockdown or pharmacological inhibition of p53.

[2] Enhanced autophagy improved the survival of p53-deficient cancer cells under conditions of hypoxia and nutrient depletion, allowing them to maintain high ATP levels.

[3] Inhibition of p53 led to autophagy in enucleated cells, and cytoplasmic, not nuclear, p53 was able to repress the enhanced autophagy of p53−/− cells.

[4] Many different inducers of autophagy (for example, starvation, rapamycin and toxins affecting the endoplasmic reticulum) stimulated proteasome-mediated degradation of p53 through a pathway relying on the E3 ubiquitin ligase HDM2.

[5] Inhibition of p53 degradation prevented the activation of autophagy in several cell lines, in response to several distinct stimuli.

[6] These results provide evidence of a key signalling pathway that links autophagy to the cancer-associated dysregulation of p53.

#### 文档 42489926：Small-molecule antagonists of p53-MDM2 binding: research tools and potential therapeutics.

[0] p53 regulates a key pathway which protects normal tissues from tumor development that may result from diverse forms of stress.

[1] In the absence of stress, growth suppressive and proapoptotic activity of p53 is inhibited by MDM2 which binds p53 and negatively regulates its activity and stability.

[2] MDM2 antagonists could activate p53 and may offer a novel therapeutic approach to cancer.

[3] Recently, we identified the first potent and selective low molecular weight inhibitors of MDM2-p53 binding, the Nutlins.

[4] These molecules activate the p53 pathway and suppress tumor growth in vitro and in vivo.

[5] They represent valuable new tools for studying the p53 pathway and its defects in cancer.

[6] Nutlins induce p53-dependent apoptosis in human cancer cells but appear cytostatic to proliferating normal cells.

[7] Their potent activity against osteosarcoma xenografts suggests that MDM2 antagonists may have clinical utility in the treatment of tumors with wild-type p53.

#### 文档 31624828：Control of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53

[0] The inefficient clearance of dying cells can lead to abnormal immune responses, such as unresolved inflammation and autoimmune conditions.

[1] We show that tumor suppressor p53 controls signaling-mediated phagocytosis of apoptotic cells through its target, Death Domain1α (DD1α), which suggests that p53 promotes both the proapoptotic pathway and postapoptotic events.

[2] DD1α appears to function as an engulfment ligand or receptor that engages in homophilic intermolecular interaction at intercellular junctions of apoptotic cells and macrophages, unlike other typical scavenger receptors that recognize phosphatidylserine on the surface of dead cells.

[3] DD1α-deficient mice showed in vivo defects in clearing dying cells, which led to multiple organ damage indicative of immune dysfunction.

[4] p53-induced expression of DD1α thus prevents persistence of cell corpses and ensures efficient generation of precise immune responses.

#### 文档 9483851：Unravelling mechanisms of p53-mediated tumour suppression

[0] p53 is a crucial tumour suppressor that responds to diverse stress signals by orchestrating specific cellular responses, including transient cell cycle arrest, cellular senescence and apoptosis, which are all processes associated with tumour suppression.

[1] However, recent studies have challenged the relative importance of these canonical cellular responses for p53-mediated tumour suppression and have highlighted roles for p53 in modulating other cellular processes, including metabolism, stem cell maintenance, invasion and metastasis, as well as communication within the tumour microenvironment.

[2] In this Opinion article, we discuss the roles of classical p53 functions, as well as emerging p53-regulated processes, in tumour suppression.

#### 文档 6896063：Senescence and aging: the critical roles of p53

[0] p53 functions as a transcription factor involved in cell-cycle control, DNA repair, apoptosis and cellular stress responses.

[1] However, besides inducing cell growth arrest and apoptosis, p53 activation also modulates cellular senescence and organismal aging.

[2] Senescence is an irreversible cell-cycle arrest that has a crucial role both in aging and as a robust physiological antitumor response, which counteracts oncogenic insults.

[3] Therefore, via the regulation of senescence, p53 contributes to tumor growth suppression, in a manner strictly dependent by its expression and cellular context.

[4] In this review, we focus on the recent advances on the contribution of p53 to cellular senescence and its implication for cancer therapy, and we will discuss p53’s impact on animal lifespan.

[5] Moreover, we describe p53-mediated regulation of several physiological pathways that could mediate its role in both senescence and aging.

人工核对记录：

- 引用是否支持模型结论：UNREVIEWED
- 是否存在疑似标注问题：UNREVIEWED
- 错误类型：UNREVIEWED
- 判断理由：

### claim 212

CR is associated with higher methylation age.

- 标准标签：CONTRADICT
- Dense预测：NOT_ENOUGH_INFO
- 自报依据：insufficient_information
- 引用了完整金标准rationale：False
- 自动核对提示：[]

模型解释：

The claim refers to 'CR' (caloric restriction) being associated with higher methylation age. None of the supplied abstracts address caloric restriction or its relationship to epigenetic/methylation age. The abstracts discuss DNA methylation and aging generally, cancer, and tissue-specific methylation changes, but provide no evidence about caloric restriction. Therefore there is insufficient basis to decide.

其他条件：

- oracle_cited：CONTRADICT；与标签一致=True；依据=provided_evidence
- retrieved_bm25：CONTRADICT；与标签一致=True；依据=provided_evidence
- retrieved_dense：NOT_ENOUGH_INFO；与标签一致=False；依据=insufficient_information
- retrieved_hybrid：CONTRADICT；与标签一致=True；依据=provided_evidence
- no_evidence：NOT_ENOUGH_INFO；与标签一致=False；依据=insufficient_information
- distractor_dense：NOT_ENOUGH_INFO；与标签一致=False；依据=insufficient_information

模型引用句：

无有效引用句。

金标准rationale（与模型输入分开列出）：

- 文档22038539：Caloric restriction delays age-related methylation drift；进入Dense上下文=False
  - 句1：Epigenetic information encoded by DNA methylation is tightly regulated, but shows a striking drift associated with age that includes both gains and losses of DNA methylation at various sites.
  - 句3：Twenty-two to 30-year-old rhesus monkeys exposed to 30% caloric restriction since 7-14 years of age showed attenuation of age-related methylation drift compared to ad libitum-fed controls such that their blood methylation age appeared 7 years younger than their chronologic age.
  - 句4：Even more pronounced effects were seen in 2.7-3.2-year-old mice exposed to 40% caloric restriction starting at 0.3 years of age.
  - 句7：Caloric restriction has been shown to increase lifespan in mammals.
  - 句8：Here, the authors provide evidence that age-related methylation drift correlates with lifespan and that caloric restriction in mice and rhesus monkeys results in attenuation of age-related methylation drift.

Dense提供的完整摘要：

#### 文档 9291668： DNA methylation and healthy human aging

[0] The process of aging results in a host of changes at the cellular and molecular levels, which include senescence, telomere shortening, and changes in gene expression.

[1] Epigenetic patterns also change over the lifespan, suggesting that epigenetic changes may constitute an important component of the aging process.

[2] The epigenetic mark that has been most highly studied is DNA methylation, the presence of methyl groups at CpG dinucleotides.

[3] These dinucleotides are often located near gene promoters and associate with gene expression levels.

[4] Early studies indicated that global levels of DNA methylation increase over the first few years of life and then decrease beginning in late adulthood.

[5] Recently, with the advent of microarray and next-generation sequencing technologies, increases in variability of DNA methylation with age have been observed, and a number of site-specific patterns have been identified.

[6] It has also been shown that certain CpG sites are highly associated with age, to the extent that prediction models using a small number of these sites can accurately predict the chronological age of the donor.

[7] Together, these observations point to the existence of two phenomena that both contribute to age-related DNA methylation changes: epigenetic drift and the epigenetic clock.

[8] In this review, we focus on healthy human aging throughout the lifetime and discuss the dynamics of DNA methylation as well as how interactions between the genome, environment, and the epigenome influence aging rates.

[9] We also discuss the impact of determining 'epigenetic age' for human health and outline some important caveats to existing and future studies.

#### 文档 11935250：Widespread and tissue specific age-related DNA methylation changes in mice.

[0] Aberrant methylation of promoter CpG islands in cancer is associated with silencing of tumor-suppressor genes, and age-dependent hypermethylation in normal appearing mucosa may be a risk factor for human colon cancer.

[1] It is not known whether this age-related DNA methylation phenomenon is specific to human tissues.

[2] We performed comprehensive DNA methylation profiling of promoter regions in aging mouse intestine using methylated CpG island amplification in combination with microarray analysis.

[3] By comparing C57BL/6 mice at 3-mo-old versus 35-mo-old for 3627 detectable autosomal genes, we found 774 (21%) that showed increased methylation and 466 (13%) that showed decreased methylation.

[4] We used pyrosequencing to quantitatively validate the microarray data and confirmed linear age-related methylation changes for all 12 genomic regions examined.

[5] We then examined 11 changed genomic loci for age-related methylation in other tissues.

[6] Of these, three of 11 showed similar changes in lung, seven of 11 changed in liver, and six of 11 changed in spleen, though to a lower degree than the changes seen in colon.

[7] There was partial conservation between age-related hypermethylation in human and mouse intestines, and Polycomb targets in embryonic stem cells were enriched among the hypermethylated genes.

[8] Our findings demonstrate a surprisingly high rate of hyper- and hypomethylation as a function of age in normal mouse small intestine tissues and a strong tissue-specificity to the process.

[9] We conclude that epigenetic deregulation is a common feature of aging in mammals.

#### 文档 4679264：DNA Methylation in the Human Cerebral Cortex Is Dynamically Regulated throughout the Life Span and Involves Differentiated Neurons

[0] The role of DNA cytosine methylation, an epigenetic regulator of chromatin structure and function, during normal and pathological brain development and aging remains unclear.

[1] Here, we examined by MethyLight PCR the DNA methylation status at 50 loci, encompassing primarily 5′ CpG islands of genes related to CNS growth and development, in temporal neocortex of 125 subjects ranging in age from 17 weeks of gestation to 104 years old.

[2] Two psychiatric disease cohorts—defined by chronic neurodegeneration (Alzheimer's) or lack thereof (schizophrenia)—were included.

[3] A robust and progressive rise in DNA methylation levels across the lifespan was observed for 8/50 loci (GABRA2, GAD1, HOXA1, NEUROD1, NEUROD2, PGR, STK11, SYK) typically in conjunction with declining levels of the corresponding mRNAs.

[4] Another 16 loci were defined by a sharp rise in DNA methylation levels within the first few months or years after birth.

[5] Disease-associated changes were limited to 2/50 loci in the Alzheimer's cohort, which appeared to reflect an acceleration of the age-related change in normal brain.

[6] Additionally, methylation studies on sorted nuclei provided evidence for bidirectional methylation events in cortical neurons during the transition from childhood to advanced age, as reflected by significant increases at 3, and a decrease at 1 of 10 loci.

[7] Furthermore, the DNMT3a de novo DNA methyl-transferase was expressed across all ages, including a subset of neurons residing in layers III and V of the mature cortex.

[8] Therefore, DNA methylation is dynamically regulated in the human cerebral cortex throughout the lifespan, involves differentiated neurons, and affects a substantial portion of genes predominantly by an age-related increase.

#### 文档 7808055：DNA methylation age of human tissues and cell types

[0] BACKGROUND It is not yet known whether DNA methylation levels can be used to accurately predict age across a broad spectrum of human tissues and cell types, nor whether the resulting age prediction is a biologically meaningful measure.    

[1] RESULTS I developed a multi-tissue predictor of age that allows one to estimate the DNA methylation age of most tissues and cell types.

[2] The predictor, which is freely available, was developed using 8,000 samples from 82 Illumina DNA methylation array datasets, encompassing 51 healthy tissues and cell types.

[3] I found that DNA methylation age has the following properties: first, it is close to zero for embryonic and induced pluripotent stem cells; second, it correlates with cell passage number; third, it gives rise to a highly heritable measure of age acceleration; and, fourth, it is applicable to chimpanzee tissues.

[4] Analysis of 6,000 cancer samples from 32 datasets showed that all of the considered 20 cancer types exhibit significant age acceleration, with an average of 36 years.

[5] Low age-acceleration of cancer tissue is associated with a high number of somatic mutations and TP53 mutations, while mutations in steroid receptors greatly accelerate DNA methylation age in breast cancer.

[6] Finally, I characterize the 353 CpG sites that together form an aging clock in terms of chromatin states and tissue variance.    

[7] CONCLUSIONS I propose that DNA methylation age measures the cumulative effect of an epigenetic maintenance system.

[8] This novel epigenetic clock can be used to address a host of questions in developmental biology, cancer and aging research.

#### 文档 23665162：Association of hypomethylation of LINE-1 repetitive element in blood leukocyte DNA with an increased risk of hepatocellular carcinoma

[0] Global DNA hypomethylation has been associated with increased risk for cancers of the colorectum, bladder, breast, head and neck, and testicular germ cells.

[1] The aim of this study was to examine whether global hypomethylation in blood leukocyte DNA is associated with the risk of hepatocellular carcinoma (HCC).

[2] A total of 315 HCC cases and 356 age-, sex- and HBsAg status-matched controls were included.

[3] Global methylation in blood leukocyte DNA was estimated by analyzing long interspersed element-1 (LINE-1) repeats using bisulfite-polymerase chain reaction (PCR) and pyrosequencing.

[4] We observed that the median methylation level in HCC cases (percentage of 5-methylcytosine (5mC)=77.7%) was significantly lower than that in controls (79.5% 5mC) (P=0.004, Wilcoxon rank-sum test).

[5] The odds ratios (ORs) of HCC for individuals in the third, second, and first (lowest) quartiles of LINE-1 methylation were 1.1 (95% confidence interval (CI) 0.7–1.8), 1.4 (95% CI 0.8–2.2), and 2.6 (95% CI 1.7–4.1) (P for trend <0.001), respectively, compared to individuals in the fourth (highest) quartile.

[6] A 1.9-fold (95% CI 1.4–2.6) increased risk of HCC was observed among individuals with LINE-1 methylation below the median compared to individuals with higher (>median) LINE-1 methylation.

[7] Our results demonstrate for the first time that individuals with global hypomethylation measured in LINE-1 repeats in blood leukocyte DNA have an increased risk for HCC.

[8] Our data provide the evidence that global hypomethylation detected in the easily obtainable DNA source of blood leukocytes may help identify individuals at risk of HCC.

人工核对记录：

- 引用是否支持模型结论：不适用，Dense回答NEI，没有引用。
- 是否存在疑似标注问题：初步未发现。
- 错误类型：检索遗漏相关证据，可能影响最终判断。
- 判断理由：Dense前5篇没有提供CR与甲基化年龄关系的直接证据。Oracle文档22038539第3句报告热量限制组的甲基化年龄更年轻，与论断中的“更高”方向相反。

## 未命中标注证据，标签一致

### claim 261

Chronic aerobic exercise alters endothelial function, improving vasodilating mechanisms mediated by NO.

- 标准标签：SUPPORT
- Dense预测：SUPPORT
- 自报依据：provided_evidence
- 引用了完整金标准rationale：False
- 自动核对提示：['CHECK_UNANNOTATED_EVIDENCE_OR_MODEL_KNOWLEDGE']

模型解释：

Multiple supplied abstracts provide direct evidence that chronic aerobic exercise increases NO production and alters endothelial function. In elderly women, 3 months of aerobic training significantly increased plasma NOx and cGMP (32322418, sentences 10-11). In healthy young humans, 8 weeks of cycling training significantly increased plasma NOx (25822299, sentences 9, 15). In rats, chronic exercise increased eNOS and iNOS gene expression in aortic endothelial cells and blunted phenylephrine-induced vascular responses via increased NO release (46743299, sentences 0, 7, 8). The coronary circulation review also states that exercise training induces endothelium-mediated adaptations and alters the phenotype of coronary endothelial cells (35271381, sentences 4, 9). Together these support the claim that chronic aerobic exercise alters endothelial function and improves NO-mediated vasodilating mechanisms.

其他条件：

- oracle_cited：SUPPORT；与标签一致=True；依据=provided_evidence
- retrieved_bm25：SUPPORT；与标签一致=True；依据=provided_evidence
- retrieved_dense：SUPPORT；与标签一致=True；依据=provided_evidence
- retrieved_hybrid：SUPPORT；与标签一致=True；依据=provided_evidence
- no_evidence：SUPPORT；与标签一致=True；依据=model_knowledge
- distractor_dense：SUPPORT；与标签一致=True；依据=provided_evidence

模型引用句：

- 文档25822299，句9：After the exercise training, the plasma concentration of NOx significantly increased (30.69 +/-
- 文档25822299，句15：The present study suggests that chronic exercise causes an increase in production of NO and a decrease in production of ET-1 in humans, which may produce beneficial effects (i.e., vasodilative and antiatherosclerotic) on the cardiovascular system.
- 文档32322418，句10：The plasma concentration of NOx significantly increased by the exercise training, and the plasma concentration of cGMP also increased by the exercise training.
- 文档32322418，句11：The present study suggests that even a mild regular aerobic-endurance exercise increases NO production in previously sedentary older humans, which may have beneficial effects (i.e., antihypertensive and antiatherosclerotic effects by endogenous NO) on the cardiovascular system.
- 文档35271381，句4：Adaptations in endothelium-mediated control play a role in training-induced changes in control of coronary vascular resistance, and there is evidence that the effects of training may be different in large coronary arteries than in the microcirculation.
- 文档35271381，句9：Although much remains to be studied, evidence clearly indicates that chronic exercise alters the phenotype of coronary endothelial and vascular smooth muscle cells and that plasticity of these cells plays a role in adaptation of the cardiovascular system in exercise training.
- 文档46743299，句0：Chronic exercise upregulates endothelial nitric oxide synthase (eNOS) gene expression.
- 文档46743299，句7：We found that (1) expression of iNOS and eNOS mRNA in endothelial cells was increased by chronic exercise and (2) chronic exercise blunted phenylephrine-induced vascular responses, probably by increasing NO release via iNOS.
- 文档46743299，句8：Our results show that chronic exercise increases both iNOS and eNOS gene expression in endothelium.

金标准rationale（与模型输入分开列出）：

- 文档10697096：Vasodilator responses of coronary resistance arteries of exercise-trained pigs.；进入Dense上下文=False
  - 句12：CONCLUSIONS These results suggest that exercise training enhances bradykinin-induced vasodilation through increased endothelium-derived relaxing factor/nitric oxide production by the L-arginine/nitric oxide synthase pathway.
- 文档1122279：Endothelium-mediated relaxation of porcine collateral-dependent arterioles is improved by exercise training.；进入Dense上下文=False
  - 句5：Relaxation to the endothelium-dependent vasodilator bradykinin was decreased (P<0.05) in arterioles isolated from collateral-dependent LCx versus nonoccluded LAD regions of SED animals.
  - 句10：CONCLUSIONS These data indicate that exercise training enhances bradykinin-mediated relaxation of collateral-dependent LCx arterioles isolated after chronic coronary occlusion, most likely because of effects on ecNOS mRNA expression and increased production of NO.

Dense提供的完整摘要：

#### 文档 32322418：Moderate regular exercise increases basal production of nitric oxide in elderly women.

[0] Vascular endothelial cells produce nitric oxide (NO), which is a potent vasodilator substance and is thought to have antiatherosclerotic properties.

[1] Therefore, it has also been proposed that NO may be useful to regulate vascular tonus and prevent progression of atherosclerosis.

[2] On the other hand, NO activity reduces with aging.

[3] We previously reported that the plasma nitrite/nitrate (NOx: the stable end product of NO) concentration was significantly increased by intense aerobic exercise training in healthy young humans.

[4] We hypothesized that lifestyle modification (e.g., even mild regular exercise training) can increase NO production in previously sedentary older humans.

[5] We measured the plasma NOx concentration before and after a mild aerobic exercise training regimen (cycling on a leg ergometer at 80% ventilatory threshold for 30 min, 5 days/week) for 3 months in elderly women.

[6] In addition, we assessed the plasma concentration of cyclic guanosine monophosphate (cGMP), a second messenger of NO, in the same samples.

[7] The individual ventilatory threshold increased significantly after the 3-month exercise training.

[8] The blood pressure at rest significantly decreased after exercise training.

[9] These results suggest that the 3-month exercise training in the older women produced favorable physiological effects.

[10] The plasma concentration of NOx significantly increased by the exercise training, and the plasma concentration of cGMP also increased by the exercise training.

[11] The present study suggests that even a mild regular aerobic-endurance exercise increases NO production in previously sedentary older humans, which may have beneficial effects (i.e., antihypertensive and antiatherosclerotic effects by endogenous NO) on the cardiovascular system.

#### 文档 25822299：Effects of exercise training of 8 weeks and detraining on plasma levels of endothelium-derived factors, endothelin-1 and nitric oxide, in healthy young humans.

[0] Vascular endothelial cells produce nitric oxide (NO), which is a potent vasodilator substance and has been proposed as having antiatherosclerotic property.

[1] Vascular endothelial cells also produce endothelin-1 (ET-1), which is a potent vasoconstrictor peptide and has potent proliferating activity on vascular smooth muscle cells.

[2] Therefore, ET-1 has been implicated in the progression of atheromatous vascular disease.

[3] Because exercise training has been reported to produce an alteration in the function of vascular endothelial cells in animals, we hypothesized that exercise training influences the production of NO and ET-1 in humans.

[4] The purpose of the present study was to examine whether chronic exercise could influence the plasma levels of NO (measured as the stable end product of NO, i.e., nitrite/nitrate [NOx]) and ET-1 in humans.

[5] Eight healthy young subjects (20.3 +/-

[6] 0.5 yr old) participated in the study and exercised by cycling on a leg ergometer (70% VO2max for 1 hour, 3-4 days/week) for 8 weeks.

[7] Venous plasma concentrations of NOx and ET-1 were measured before and after (immediately before the end of 8-week exercise training) the exercise training, and also after the 4th and 8th week after the cessation of training.

[8] The VO2max significantly increased after exercise training.

[9] After the exercise training, the plasma concentration of NOx significantly increased (30.69 +/-

[10] 3.20 vs. 48.64 +/-

[11] 8.16 micromol/L, p < 0.05), and the plasma concentration of ET-1 significantly decreased (1.65 +/- 0.14 vs. 1.23 +/-

[12] 0.12 pg/mL, p < 0.05).

[13] The increase in NOx level and the decrease in ET-1 level lasted to the 4th week after the cessation of exercise training and these levels (levels of NOx and ET-1) returned to the basal levels (the levels before the exercise training) in the 8th week after the cessation of exercise training.

[14] There was a significant negative correlation between plasma NOx concentration and plasma ET-1 concentration.

[15] The present study suggests that chronic exercise causes an increase in production of NO and a decrease in production of ET-1 in humans, which may produce beneficial effects (i.e., vasodilative and antiatherosclerotic) on the cardiovascular system.

#### 文档 46743299：Chronic Exercise Increases Both Inducible and Endothelial Nitric Oxide Synthase Gene Expression in Endothelial Cells of Rat Aorta

[0] Chronic exercise upregulates endothelial nitric oxide synthase (eNOS) gene expression.

[1] Whether the expression of inducible nitric oxide synthase (iNOS) is affected by exercise is unknown.

[2] We therefore investigated the effects of chronic exercise on iNOS and eNOS expression in isolated rat aortic endothelial and smooth muscle cells separately.

[3] Five-week-old male Wistar rats were randomly divided into control and exercise groups.

[4] After 10 weeks of running training, animals were sacrificed under ether anesthesia.

[5] The standard curve quantitative competitive reverse transcriptase-polymerase chain reaction method was used to quantify NOS mRNA expression in isolated endothelial/smooth muscle cells.

[6] To evaluate the functional role of iNOS, we examined phenylephrine-induced vascular responses with or without pretreatment with aminoguanidine.

[7] We found that (1) expression of iNOS and eNOS mRNA in endothelial cells was increased by chronic exercise and (2) chronic exercise blunted phenylephrine-induced vascular responses, probably by increasing NO release via iNOS.

[8] Our results show that chronic exercise increases both iNOS and eNOS gene expression in endothelium.

[9] These alterations may be partially responsible for the change in vascular response after exercise.

#### 文档 35271381：Exercise training-induced adaptations in the coronary circulation.

[0] Aerobic exercise training induces an increase in coronary blood flow capacity that is associated with altered control of coronary vascular resistance and, therefore, coronary blood flow.

[1] The relative importance of metabolic, myogenic, endothelium-mediated, and neurohumoral control systems varies throughout the coronary arterial tree, and these control systems contribute in parallel to regulating coronary vascular resistance to differing degrees at each level in the coronary arterial tree.

[2] In addition to this nonuniformity of the relative importance of vascular control systems in the coronary arterial tree, it appears that exercise training-induced adaptations are also distributed spatially, in a nonuniform manner throughout the coronary tree.

[3] As a result, it is necessary to examine training-induced adaptations throughout the coronary arterial tree.

[4] Adaptations in endothelium-mediated control play a role in training-induced changes in control of coronary vascular resistance, and there is evidence that the effects of training may be different in large coronary arteries than in the microcirculation.

[5] Also, there is evidence that the mode, frequency, and intensity of exercise training bouts and duration of training may influence the adaptive changes in endothelial function.

[6] Exercise training has also been shown to induce changes in responses of coronary vascular smooth muscle to vasoactive agents and alterations in the cellular-molecular control of intracellular Ca2+ in coronary vascular smooth muscle of conduit coronary arteries and to enhance myogenic reactivity of coronary resistance arteries.

[7] Exercise training also appears to have different effects on vascular smooth muscle in large coronary arteries than in the microcirculation.

[8] For example, adenosine sensitivity is increased in conduit coronary arteries and large resistance arteries after training but is not altered in small coronary resistance arteries of trained animals.

[9] Although much remains to be studied, evidence clearly indicates that chronic exercise alters the phenotype of coronary endothelial and vascular smooth muscle cells and that plasticity of these cells plays a role in adaptation of the cardiovascular system in exercise training.

#### 文档 17097974：Exercise causes a tissue-specific change of NO production in the kidney and lung.

[0] Nitric oxide (NO) is produced in the vascular endothelium and is a potent vasodilator substance that participates in the regulation of local vascular tone.

[1] Exercise causes peculiar changes in systemic and regional blood flow, i.e., an increase of systemic blood flow and a redistribution of local tissue blood flow, by which the blood flow is greatly increased in the working muscles, whereas it is decreased in some organs such as the kidney and intestine.

[2] Thus we hypothesized that exercise causes a tissue-specific change of NO production in some internal organs.

[3] We studied whether exercise affects expression of NO synthase (NOS) mRNA and protein, NOS activity, and tissue level of nitrite/nitrate (stable end products of NO) in the kidneys (in which blood flow during exercise is decreased) and lungs (in which blood flow during exercise is increased with the increase of cardiac output) of rat.

[4] Rats ran on a treadmill for 45 min at a speed of 25 m/min.

[5] Immediately after this exercise, kidneys and lungs were quickly removed.

[6] Control rats remained at rest during this 45-min period.

[7] Expression of endothelial NOS (eNOS) mRNA in the kidneys was markedly lower in exercise rats than in control rats, whereas that in the lungs was significantly higher in exercise rats than in control rats.

[8] Western blot analysis confirmed down- and upregulation of eNOS protein in the kidney and lung, respectively, after exercise.

[9] On the other hand, neither expression of neuronal NOS (nNOS) mRNA and nNOS protein nor inducible NOS (iNOS) mRNA and iNOS protein in the kidneys and lungs differed between exercise and control rats.

[10] NOS activity in the kidney was significantly lower in exercise rats than in control rats, whereas that in the lung was significantly higher in exercise rats than in control rats.

[11] On the other hand, the iNOS activity in the kidneys and lungs did not differ between exercise rats and control rats.

[12] Tissue nitrite/nitrate level in the kidneys was markedly lower in exercise rats, whereas that in the lungs was significantly higher in exercise rats.

[13] The present results show that production of NO is markedly and tissue-specifically changed in the kidney and lung by exercise.

人工核对记录：

- 引用是否支持模型结论：初步支持，但应保留原摘要中的“提示”“可能”等限定。
- 是否存在疑似标注问题：初步未发现标签问题；检索结果可能包含未被标注的替代证据。
- 错误类型：非标签错误；未命中标注文档，但找到替代证据。
- 判断理由：Dense未检索到数据集标注的文档10697096和1122279，
  但提供的其他摘要涉及长期运动、NO生成及血管反应。
  文档25822299句15认为长期运动增加NO生成，并可能产生血管舒张等有益作用；
  文档46743299句7报告长期运动改变内皮相关基因表达和血管反应，
  并提出这可能与NO释放增加有关。
  这些引用支持论断的主要方向，因此不能仅凭未命中标注文档，
  就认定检索结果无效或模型是在猜测。
  不过，不同研究的对象和测量指标存在差异，不宜表述为完全证明该论断。

### claim 295

Crosstalk between dendritic cells (DCs) and innate lymphoid cells (ILCs) is important in the regulation of intestinal homeostasis.

- 标准标签：SUPPORT
- Dense预测：SUPPORT
- 自报依据：provided_evidence
- 引用了完整金标准rationale：False
- 自动核对提示：['CHECK_UNANNOTATED_EVIDENCE_OR_MODEL_KNOWLEDGE']

模型解释：

Abstract 29423324 provides direct evidence of DC-ILC crosstalk in the intestine: CD14+ DCs promoted polarization of ILC3 toward CD127+ ILC1, while CD14- DCs promoted the reverse differentiation, and the authors conclude that environmental cues determine the composition and phenotype of ILC1/ILC3 in the gut, supporting the claim that DC-ILC crosstalk is important for intestinal homeostasis.

其他条件：

- oracle_cited：SUPPORT；与标签一致=True；依据=provided_evidence
- retrieved_bm25：SUPPORT；与标签一致=True；依据=provided_evidence
- retrieved_dense：SUPPORT；与标签一致=True；依据=provided_evidence
- retrieved_hybrid：SUPPORT；与标签一致=True；依据=provided_evidence
- no_evidence：SUPPORT；与标签一致=True；依据=model_knowledge
- distractor_dense：SUPPORT；与标签一致=True；依据=provided_evidence

模型引用句：

- 文档29423324，句4：Furthermore, we observed in resection specimen from Crohn's disease patients a higher proportion of CD14(+) dendritic cells (DC), which in vitro promoted polarization from ILC3 to CD127(+) ILC1.
- 文档29423324，句5：In contrast, CD14(-) DCs promoted differentiation from CD127(+) ILC1 toward ILC3.
- 文档29423324，句6：These observations suggest that environmental cues determine the composition, function, and phenotype of CD127(+) ILC1 and ILC3 in the gut.

金标准rationale（与模型输入分开列出）：

- 文档20310709：The Transcription Factor T-bet Regulates Intestinal Inflammation Mediated by Interleukin-7 Receptor+ Innate Lymphoid Cells；进入Dense上下文=False
  - 句2：TNF-α produced by CD103(-)CD11b(+) dendritic cells synergized with IL-23 to drive IL-17A production by ILCs, demonstrating a previously unrecognized layer of cellular crosstalk between dendritic cells and ILCs.
  - 句4：Crucially, T-bet also suppressed the expression of IL-7R, a key molecule involved in controlling intestinal ILC homeostasis.
  - 句5：The importance of IL-7R signaling in TRUC disease was highlighted by the dramatic reduction in intestinal ILCs and attenuated colitis following IL-7R blockade.
  - 句6：Taken together, these data demonstrate the mechanism by which T-bet regulates the complex interplay between mucosal dendritic cells, ILCs, and the intestinal microbiota.

Dense提供的完整摘要：

#### 文档 24044977：Innate lymphoid cells: emerging insights in development, lineage relationships, and function.

[0] Innate lymphoid cells (ILCs) are immune cells that lack a specific antigen receptor yet can produce an array of effector cytokines that in variety match that of T helper cell subsets.

[1] ILCs function in lymphoid organogenesis, tissue remodeling, antimicrobial immunity, and inflammation, particularly at barrier surfaces.

[2] Their ability to promptly respond to insults inflicted by stress-causing microbes strongly suggests that ILCs are critical in first-line immunological defenses.

[3] Here, we review current data on developmental requirements, lineage relationships, and effector functions of two families of ILCs: (a) Rorγt-expressing cells involved in lymphoid tissue formation, mucosal immunity, and inflammation and (b) type 2 ILCs that are important for helminth immunity.

[4] We also discuss the potential roles of ILCs in the pathology of immune-mediated inflammatory and infectious diseases including allergy.

#### 文档 29423324：Interleukin-12 and -23 Control Plasticity of CD127(+) Group 1 and Group 3 Innate Lymphoid Cells in the Intestinal Lamina Propria.

[0] Human group 1 ILCs consist of at least three phenotypically distinct subsets, including NK cells, CD127(+) ILC1, and intraepithelial CD103(+) ILC1.

[1] In inflamed intestinal tissues from Crohn's disease patients, numbers of CD127(+) ILC1 increased at the cost of ILC3.

[2] Here we found that differentiation of ILC3 to CD127(+) ILC1 is reversible in vitro and in vivo.

[3] CD127(+) ILC1 differentiated to ILC3 in the presence of interleukin-2 (IL-2), IL-23, and IL-1β dependent on the transcription factor RORγt, and this process was enhanced in the presence of retinoic acid.

[4] Furthermore, we observed in resection specimen from Crohn's disease patients a higher proportion of CD14(+) dendritic cells (DC), which in vitro promoted polarization from ILC3 to CD127(+) ILC1.

[5] In contrast, CD14(-) DCs promoted differentiation from CD127(+) ILC1 toward ILC3.

[6] These observations suggest that environmental cues determine the composition, function, and phenotype of CD127(+) ILC1 and ILC3 in the gut.

#### 文档 1022115：IL-23–responsive innate lymphoid cells are increased in inflammatory bowel disease

[0] Results of experimental and genetic studies have highlighted the role of the IL-23/IL-17 axis in the pathogenesis of inflammatory bowel disease (IBD).

[1] IL-23-driven inflammation has been primarily linked to Th17 cells; however, we have recently identified a novel population of innate lymphoid cells (ILCs) in mice that produces IL-17, IL-22, and IFN-γ in response to IL-23 and mediates innate colitis.

[2] The relevance of ILC populations in human health and disease is currently poorly understood.

[3] In this study, we have analyzed the role of IL-23-responsive ILCs in the human intestine in control and IBD patients.

[4] Our results show increased expression of the Th17-associated cytokine genes IL17A and IL17F among intestinal CD3⁻ cells in IBD.

[5] IL17A and IL17F expression is restricted to CD56⁻ ILCs, whereas IL-23 induces IL22 and IL26 in the CD56⁺ ILC compartment.

[6] Furthermore, we observed a significant and selective increase in CD127⁺CD56⁻ ILCs in the inflamed intestine in Crohn's disease (CD) patients but not in ulcerative colitis patients.

[7] These results indicate that IL-23-responsive ILCs are present in the human intestine and that intestinal inflammation in CD is associated with the selective accumulation of a phenotypically distinct ILC population characterized by inflammatory cytokine expression.

[8] ILCs may contribute to intestinal inflammation through cytokine production, lymphocyte recruitment, and organization of the inflammatory tissue and may represent a novel tissue-specific target for subtypes of IBD.

#### 文档 22791348：The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting.

[0] Dendritic cells (DCs) form a remarkable cellular network that shapes adaptive immune responses according to peripheral cues.

[1] After four decades of research, we now know that DCs arise from a hematopoietic lineage distinct from other leukocytes, establishing the DC system as a unique hematopoietic branch.

[2] Recent work has also established that tissue DCs consist of developmentally and functionally distinct subsets that differentially regulate T lymphocyte function.

[3] This review discusses major advances in our understanding of the regulation of DC lineage commitment, differentiation, diversification, and function in situ.

#### 文档 13231899：In situ regulation of DC subsets and T cells mediates tumor regression in mice.

[0] Vaccines are largely ineffective for patients with established cancer, as advanced disease requires potent and sustained activation of CD8(+) cytotoxic T lymphocytes (CTLs) to kill tumor cells and clear the disease.

[1] Recent studies have found that subsets of dendritic cells (DCs) specialize in antigen cross-presentation and in the production of cytokines, which regulate both CTLs and T regulatory (Treg) cells that shut down effector T cell responses.

[2] Here, we addressed the hypothesis that coordinated regulation of a DC network, and plasmacytoid DCs (pDCs) and CD8(+) DCs in particular, could enhance host immunity in mice.

[3] We used functionalized biomaterials incorporating various combinations of an inflammatory cytokine, immune danger signal, and tumor lysates to control the activation and localization of host DC populations in situ.

[4] The numbers of pDCs and CD8(+) DCs, and the endogenous production of interleukin-12, all correlated strongly with the magnitude of protective antitumor immunity and the generation of potent CD8(+) CTLs.

[5] Vaccination by this method maintained local and systemic CTL responses for extended periods while inhibiting FoxP3 Treg activity during antigen clearance, resulting in complete regression of distant and established melanoma tumors.

[6] The efficacy of this vaccine as a monotherapy against large invasive tumors may be a result of the local activity of pDCs and CD8(+) DCs induced by persistent danger and antigen signaling at the vaccine site.

[7] These results indicate that a critical pattern of DC subsets correlates with the evolution of therapeutic antitumor responses and provide a template for future vaccine design.

人工核对记录：

- 引用是否支持模型结论：UNREVIEWED
- 是否存在疑似标注问题：UNREVIEWED
- 错误类型：UNREVIEWED
- 判断理由：

## NEI被预测为其他标签

### claim 36

A deficiency of vitamin B12 increases blood levels of homocysteine.

- 标准标签：NOT_ENOUGH_INFO
- Dense预测：SUPPORT
- 自报依据：model_knowledge
- 引用了完整金标准rationale：None
- 自动核对提示：['CHECK_ANNOTATION_SCOPE_AND_KNOWLEDGE_POLICY']

模型解释：

Vitamin B12 is a required cofactor for methionine synthase, which converts homocysteine to methionine. A deficiency of vitamin B12 impairs this remethylation pathway, leading to accumulation of homocysteine in the blood. This is well-established biochemistry and clinical knowledge, though the provided abstracts focus on folate rather than B12 deficiency.

其他条件：

- oracle_cited：NOT_ENOUGH_INFO；与标签一致=True；依据=insufficient_information
- retrieved_bm25：SUPPORT；与标签一致=False；依据=model_knowledge
- retrieved_dense：SUPPORT；与标签一致=False；依据=model_knowledge
- retrieved_hybrid：SUPPORT；与标签一致=False；依据=model_knowledge
- no_evidence：SUPPORT；与标签一致=False；依据=model_knowledge
- distractor_dense：SUPPORT；与标签一致=False；依据=model_knowledge

模型引用句：

无有效引用句。

金标准rationale（与模型输入分开列出）：

NEI没有正向证据标注。

Dense提供的完整摘要：

#### 文档 18557974：British Journal of Nutrition (2003), 89, 295–301 q The Authors 2003 DOI: 10.1079/BJN2002776 Plasma homocysteine concentration is decreased by dietary intervention*

[0] High plasma total homocysteine (tHcy) concentration is reported to be a risk factor for vascular diseases.

[1] We investigated the extent to which serum folate and plasma tHcy respond to a high intake of natural folate from food.

[2] Thirty-seven healthy females volunteered t o participate in a crossover dietary intervention.

[3] The study included a baseline period and two 5-week diet periods (low- and high-folate diets) with a 3-week washout in between.

[4] The low-folate diet contained one serving of both vegetables and fruit/d, while during the high-folate diet the subjects ate at least seven servings of vegetables, berries, and citrus fruit/d.

[5] Serum and erythrocyte (RBC) folate, serum vitamin B (12), and plasma tHcy concentrations were measured at the base-line and at the end of each diet period.

[6] The mean concentrations of serum and RBC folate were 11.0 (SD 3.0) nmol/l and 412 (SD 120) nmol/l at the end of the low-folate diet and 78 (95 % CI 62, 94) % and 14 (95 % CI 8, 20) % higher in response to the high-folate diet (P< 0.001).

[7] The serum concentration of vitamin B12 remained unchanged during the intervention.

[8] The mean plasma tHcy concentration was 8.0 pmol/ at the end of the low-folate diet and decreased by 13 (95% CI 9, 18) % in response to the high-folate diet (P<0.001).

[9] In conclusion, a diet high in fresh berries, citrus fruit, and vegetables effectively increases serum and RBC folate and decreases plasma homocysteine.

#### 文档 21636085：The effect of folic acid supplementation on plasma homocysteine in an elderly population.

[0] BACKGROUND Increased plasma homocysteine is associated with coronary artery disease, peripheral vascular disease and venous thrombosis.

[1] Folic acid is the most effective therapy for reducing homocysteine levels.

[2] The lowest effective supplement of folic acid is not known, particularly for the elderly who have the highest prevalence of these conditions.   

[3] AIM To explore the effects of daily supplements of 0, 50, 100, 200, 400 and 600 microg folic acid on plasma homocysteine in an elderly population.    

[4] DESIGN Randomized double-blind placebo-controlled trial.    

[5] METHODS Participants (n=368) aged 65-75 years were randomly allocated to receive one of the treatments for 6 weeks.

[6] Plasma homocysteine was recorded after 3 weeks and 6 weeks of supplementation.    

[7] RESULTS Only the 400 microg and 600 microg groups had significantly lower homocysteine levels compared to placebo (p=0.038 and p<0.001, respectively).

[8] Using multiple linear regression and each individual's total folic acid intake (diet plus supplement), a total daily folic acid intake of 926 microg per day would be required to ensure that 95% of the elderly population would be without cardiovascular risk from folate deficiency.   

[9] DISCUSSION A daily folic acid intake of 926 microg is unlikely to be achieved by diet alone.

[10] Individual supplementation or fortification of food with folic acid will be required to reach this target.

#### 文档 33409100：Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.

[0] CONTEXT High plasma homocysteine levels are a risk factor for mortality and vascular disease in observational studies of patients with chronic kidney disease.

[1] Folic acid and B vitamins decrease homocysteine levels in this population but whether they lower mortality is unknown.    

[2] OBJECTIVE To determine whether high doses of folic acid and B vitamins administered daily reduce mortality in patients with chronic kidney disease.    

[3] DESIGN, SETTING, AND PARTICIPANTS Double-blind randomized controlled trial (2001-2006) in 36 US Department of Veterans Affairs medical centers.

[4] Median follow-up was 3.2 years for 2056 participants aged 21 years or older with advanced chronic kidney disease (estimated creatinine clearance < or =30 mL/min) (n = 1305) or end-stage renal disease (n = 751) and high homocysteine levels (> or = 15 micromol/L).    

[5] INTERVENTION Participants received a daily capsule containing 40 mg of folic acid, 100 mg of pyridoxine hydrochloride (vitamin B6), and 2 mg of cyanocobalamin (vitamin B12) or a placebo.    

[6] MAIN OUTCOME MEASURES The primary outcome was all-cause mortality.

[7] Secondary outcomes included myocardial infarction (MI), stroke, amputation of all or part of a lower extremity, a composite of these 3 plus all-cause mortality, time to initiation of dialysis, and time to thrombosis of arteriovenous access in hemodialysis patients.    

[8] RESULTS Mean baseline homocysteine level was 24.0 micromol/L in the vitamin group and 24.2 micromol/L in the placebo group.

[9] It was lowered 6.3 micromol/L (25.8%; P < .001) in the vitamin group and 0.4 micromol/L (1.7%; P = .14) in the placebo group at 3 months, but there was no significant effect on mortality (448 vitamin group deaths vs 436 placebo group deaths) (hazard ratio [HR], 1.04; 95% CI, 0.91-1.18).

[10] No significant effects were demonstrated for secondary outcomes or adverse events: there were 129 MIs in the vitamin group vs 150 for placebo (HR, 0.86; 95% CI, 0.67-1.08), 37 strokes in the vitamin group vs 41 for placebo (HR, 0.90; 95% CI, 0.58-1.40), and 60 amputations in the vitamin group vs 53 for placebo (HR, 1.14; 95% CI, 0.79-1.64).

[11] In addition, the composite of MI, stroke, and amputations plus mortality (P = .85), time to dialysis (P = .38), and time to thrombosis in hemodialysis patients (P = .97) did not differ between the vitamin and placebo groups.    

[12] CONCLUSION Treatment with high doses of folic acid and B vitamins did not improve survival or reduce the incidence of vascular disease in patients with advanced chronic kidney disease or end-stage renal disease.    

[13] TRIAL REGISTRATION clinicaltrials.gov Identifier: NCT00032435.

#### 文档 37424881：The effect of folate fortification on folic acid-based homocysteine-lowering intervention and stroke risk: a meta-analysis.

[0] OBJECTIVE Folate and vitamin B12 are two vital regulators in the metabolic process of homocysteine, which is a risk factor of atherothrombotic events.

[1] Low folate intake or low plasma folate concentration is associated with increased stroke risk.

[2] Previous randomized controlled trials presented discordant findings in the effect of folic acid supplementation-based homocysteine lowering on stroke risk.

[3] The aim of the present review was to perform a meta-analysis of relevant randomized controlled trials to check the how different folate fortification status might affect the effects of folic acid supplementation in lowering homocysteine and reducing stroke risk.    

[4] DESIGN Relevant randomized controlled trials were identified through formal literature search.

[5] Homocysteine reduction was compared in subgroups stratified by folate fortification status.

[6] Relative risks with 95 % confidence intervals were used as a measure to assess the association between folic acid supplementation and stroke risk.    

[7] SETTING The meta-analysis included fourteen randomized controlled trials,   SUBJECTS A total of 39 420 patients.    

[8] RESULTS Homocysteine reductions were 26·99 (sd 1·91) %, 18·38 (sd 3·82) % and 21·30 (sd 1·98) %, respectively, in the subgroups without folate fortification, with folate fortification and with partial folate fortification.

[9] Significant difference was observed between the subgroups with folate fortification and without folate fortification (P=0·05).

[10] The relative risk of stroke was 0·88 (95 % CI 0·77, 1·00, P=0·05) in the subgroup without folate fortification, 0·94 (95 % CI 0·58, 1·54, P=0·82) in the subgroup with folate fortification and 0·91 (95 % CI 0·82, 1·01, P=0·09) in the subgroup with partial folate fortification.    

[11] CONCLUSIONS Folic acid supplementation might have a modest benefit on stroke prevention in regions without folate fortification.

#### 文档 11705328：Randomized trial of folic acid supplementation and serum homocysteine levels.

[0] BACKGROUND Lowering serum homocysteine levels with folic acid is expected to reduce mortality from ischemic heart disease.

[1] Homocysteine reduction is known to be maximal at a folic acid dosage of 1 mg/d, but the effect of lower doses (relevant to food fortification) is unclear.    

[2] METHODS We randomized 151 patients with ischemic heart disease to 1 of 5 dosages of folic acid (0.2, 0.4, 0.6, 0.8, and 1.0 mg/d) or placebo.

[3] Fasting blood samples for serum homocysteine and serum folate analysis were taken initially, after 3 months of supplementation, and 3 months after folic acid use was discontinued.    

[4] RESULTS Median serum homocysteine level decreased with increasing folic acid dosage, to a maximum at 0.8 mg of folic acid per day, when the homocysteine reduction (placebo adjusted) was 2.7 micromol/L (23%), similar to the known effect of folic acid dosages of 1 mg/d and above.

[5] The higher a person's initial serum homocysteine level, the greater was the response to folic acid, but there were statistically significant reductions regardless of the initial level.

[6] Serum folate level increased approximately linearly (5.5 nmol/L for every 0.1 mg of folic acid).

[7] Within-person fluctuations over time in serum homocysteine levels, measured in the placebo group, were large compared with the effect of folic acid, indicating that monitoring of the reduction in an individual is impractical.    

[8] CONCLUSIONS A dosage of folic acid of 0.8 mg/d appears necessary to achieve the maximum reduction in serum homocysteine level across the range of homocysteine levels in the population.

[9] Current US food fortification levels will achieve only a small proportion of the achievable homocysteine reduction.

人工核对记录：

- 引用是否支持模型结论：无引用，不适用；另行检查所提供摘要后，认为其不足以直接支持论断。
- 是否存在疑似标注问题：仅凭当前摘要未发现足以质疑NEI标签的直接证据；论断本身的科学真实性需另行核实。
- 错误类型：与标准标签不一致；模型自报使用已有知识，在提供的摘要缺少直接支持时作出SUPPORT判断。
- 判断理由：文档18557974研究叶酸饮食干预，且句7说明B12水平未发生变化；
  文档21636085和11705328主要研究叶酸补充。
  文档33409100同时补充叶酸、B6和B12，不能从联合干预结果单独确定B12的作用，
  也不能直接推导B12缺乏的效果。
  文档37424881句0虽提到B12参与同型半胱氨酸代谢，
  但没有明确说明B12缺乏会使其血液水平升高。
  因此，五篇摘要提供了相关背景，但不足以直接支持完整论断。
  DeepSeek未提供引用，并自报依据model_knowledge回答SUPPORT。
  该回答与数据集NEI标签不一致，但不能据此认定论断为假或模型发生幻觉。

### claim 72

Activator-inhibitor pairs are provided dorsally by Admpchordin.

- 标准标签：NOT_ENOUGH_INFO
- Dense预测：SUPPORT
- 自报依据：provided_evidence
- 引用了完整金标准rationale：None
- 自动核对提示：['CHECK_ANNOTATION_SCOPE_AND_KNOWLEDGE_POLICY']

模型解释：

The claim states that activator-inhibitor pairs are provided dorsally by Admp and Chordin. Abstract 6076903 supports this: ADMP has BMP-like (activator) activity and signals via ALK-2 (sentence 5), but is unable to signal dorsally because of inhibition by Chordin (sentence 6), and the conclusion states that dorsal and ventral BMP signals and their extracellular antagonists provide a molecular mechanism for embryonic self-regulation (sentence 9). This describes an activator (ADMP/BMP) and inhibitor (Chordin) pair operating at the dorsal pole.

其他条件：

- oracle_cited：SUPPORT；与标签一致=False；依据=provided_evidence
- retrieved_bm25：SUPPORT；与标签一致=False；依据=provided_evidence
- retrieved_dense：SUPPORT；与标签一致=False；依据=provided_evidence
- retrieved_hybrid：NOT_ENOUGH_INFO；与标签一致=True；依据=insufficient_information
- no_evidence：NOT_ENOUGH_INFO；与标签一致=True；依据=insufficient_information
- distractor_dense：NOT_ENOUGH_INFO；与标签一致=True；依据=insufficient_information

模型引用句：

- 文档6076903，句5：ADMP has BMP-like activity and signals via the ALK-2 receptor.
- 文档6076903，句6：It is unable to signal dorsally because of inhibition by Chordin.
- 文档6076903，句9：We conclude that dorsal and ventral BMP signals and their extracellular antagonists expressed under opposing transcriptional regulation provide a molecular mechanism for embryonic self-regulation.

金标准rationale（与模型输入分开列出）：

NEI没有正向证据标注。

Dense提供的完整摘要：

#### 文档 6076903：Regulation of ADMP and BMP2/4/7 at Opposite Embryonic Poles Generates a Self-Regulating Morphogenetic Field

[0] Embryos have the ability to self-regulate and regenerate normal structures after being sectioned in half.

[1] How is such a morphogenetic field established?

[2] We discovered that quadruple knockdown of ADMP and BMP2/4/7 in Xenopus embryos eliminates self-regulation, causing ubiquitous neural induction throughout the ectoderm.

[3] ADMP transcription in the Spemann organizer is activated at low BMP levels.

[4] When ventral BMP2/4/7 signals are depleted, Admp expression increases, allowing for self-regulation.

[5] ADMP has BMP-like activity and signals via the ALK-2 receptor.

[6] It is unable to signal dorsally because of inhibition by Chordin.

[7] The ventral BMP antagonists Sizzled and Bambi further refine the pattern.

[8] By transplanting dorsal or ventral wild-type grafts into ADMP/BMP2/4/7-depleted hosts, we demonstrate that both poles serve as signaling centers that can induce histotypic differentiation over considerable distances.

[9] We conclude that dorsal and ventral BMP signals and their extracellular antagonists expressed under opposing transcriptional regulation provide a molecular mechanism for embryonic self-regulation.

#### 文档 5573975：Activin–like kinase–3 activity is important for kidney regeneration and reversal of fibrosis

[0] Molecules associated with the transforming growth factor β (TGF-β) superfamily, such as bone morphogenic proteins (BMPs) and TGF-β, are key regulators of inflammation, apoptosis and cellular transitions.

[1] Here we show that the BMP receptor activin-like kinase 3 (Alk3) is elevated early in diseased kidneys after injury.

[2] We also found that its deletion in the tubular epithelium leads to enhanced TGF-β1-Smad family member 3 (Smad3) signaling, epithelial damage and fibrosis, suggesting a protective role for Alk3-mediated signaling in the kidney.

[3] A structure-function analysis of the BMP-Alk3-BMP receptor, type 2 (BMPR2) ligand-receptor complex, along with synthetic organic chemistry, led us to construct a library of small peptide agonists of BMP signaling that function through the Alk3 receptor.

[4] One such peptide agonist, THR-123, suppressed inflammation, apoptosis and the epithelial-to-mesenchymal transition program and reversed established fibrosis in five mouse models of acute and chronic renal injury.

[5] THR-123 acts specifically through Alk3 signaling, as mice with a targeted deletion for Alk3 in their tubular epithelium did not respond to therapy with THR-123.

[6] Combining THR-123 and the angiotensin-converting enzyme inhibitor captopril had an additive therapeutic benefit in controlling renal fibrosis.

[7] Our studies show that BMP signaling agonists constitute a new line of therapeutic agents with potential utility in the clinic to induce regeneration, repair and reverse established fibrosis.

#### 文档 14296612：Dorsomorphin, a Selective Small Molecule Inhibitor of BMP Signaling, Promotes Cardiomyogenesis in Embryonic Stem Cells

[0] BACKGROUND Pluripotent embryonic stem (ES) cells, which have the capacity to give rise to all tissue types in the body, show great promise as a versatile source of cells for regenerative therapy.

[1] However, the basic mechanisms of lineage specification of pluripotent stem cells are largely unknown, and generating sufficient quantities of desired cell types remains a formidable challenge.

[2] Small molecules, particularly those that modulate key developmental pathways like the bone morphogenetic protein (BMP) signaling cascade, hold promise as tools to study in vitro lineage specification and to direct differentiation of stem cells toward particular cell types.    

[3] METHODOLOGY/ PRINCIPAL FINDINGS We describe the use of dorsomorphin, a selective small molecule inhibitor of BMP signaling, to induce myocardial differentiation in mouse ES cells.

[4] Cardiac induction is very robust, increasing the yield of spontaneously beating cardiomyocytes by at least 20 fold.

[5] Dorsomorphin, unlike the endogenous BMP antagonist Noggin, robustly induces cardiomyogenesis when treatment is limited to the initial 24-hours of ES cell differentiation.

[6] Quantitative-PCR analyses of differentiating ES cells indicate that pharmacological inhibition of BMP signaling during the early critical stage promotes the development of the cardiomyocyte lineage, but reduces the differentiation of endothelial, smooth muscle, and hematopoietic cells.    

[7] CONCLUSIONS/ SIGNIFICANCE Administration of a selective small molecule BMP inhibitor during the initial stages of ES cell differentiation substantially promotes the differentiation of primitive pluripotent cells toward the cardiomyocytic lineage, apparently at the expense of other mesodermal lineages.

[8] Small molecule modulators of developmental pathways like dorsomorphin could become versatile pharmacological tools for stem cell research and regenerative medicine.

#### 文档 39291138：Integration of Smad and MAPK pathways: a link and a linker revisited.

[0] Cells develop by reading mixed signals.

[1] Nowhere is this clearer than in the highly dynamic processes that propel embryogenesis, when critical cell-fate decisions are made swiftly in response to well-orchestrated growthfactor combinations.

[2] Learning how diverse signaling pathways are integrated is therefore essential for understanding physiology.

[3] This requires the identification, in tangible molecular terms, of key nodes for pathway integration that operate in vivo.

[4] A report in this issue, on the integration of Smad and Ras/MAPK pathways during neural induction (Pera et al. 2003), provides timely insights into the relevance of one such node.

[5] Pera et al. (2003) report that FGF8 and IGF2—two growth factors that activate the Ras/MAPK pathway— favor neural differentiation and mesoderm dorsalization in Xenopus by inhibiting BMP (Bone Morphogenetic Protein) signaling.

[6] Mesoderm is formed from ectoderm in response to Nodal-related signals from the endoderm at the blastula stage and beyond (Fig. 1; for review, see De Robertis et al. 2000).

[7] BMP induces differentiation of ectoderm into epidermal cell fates at the expense of neural fates, and it ventralizes the mesoderm at the expense of dorsal fates (for review, see Weinstein and HemmatiBrivanlou 1999; De Robertis et al. 2000).

[8] Accordingly, neural differentiation and dorsal mesoderm formation are favored when BMP signaling is attenuated.

[9] Noggin, Chordin, Cerberus, and Follistatin, secreted by the Spemann organizer on the dorsal side at the gastrula stage, facilitate the formation of neural tissue by sequestering BMP (Weinstein and Hemmati-Brivanlou 1999; De Robertis et al. 2000).

[10] Experimentally blocking BMP signaling with a dominant-negative BMP receptor has a similar effect of promoting ectoderm neuralization (Weinstein and Hemmati-Brivanlou 1999).

[11] As it turns out, neural induction can also be achieved with FGF (fibroblast growth factor; Kengaku and Okamoto 1993; Lamb and Harland 1995; Hongo et al. 1999; Hardcastle et al. 2000; Streit et al. 2000; Wilson et al. 2000) and IGF (insulin-like growth factor; Pera et al. 2001; Richard-Parpaillon et al. 2002).

[12] Injection of transcripts encoding FGF8 or IFG2 into one animal-pole blastomere of a fourto eight-cell embryo results in an expanded neural plate at the injected side (Pera et al. 2003).

[13] Surprisingly, expression of a dominant-negative FGF receptor prevents neuralization of ectoderm explants by the BMP blocker Noggin (Launay et al. 1996).

[14] Likewise, the potent neuralizing effect of Chordin can be blocked by a dominant-negative FGF receptor or a morpholino oligonucleotide targeting the IGF receptor (Pera et al. 2003).

[15] Thus, the neuralizing effect of BMP inhibitors is somehow tied to FGF and IFG signaling.

[16] The question is, how?

[17] Because FGF8 and IFG2 activate MAPK, Pera et al. (2003) took heed from previous work showing that MAPK inhibits the BMP signal-transduction factor Smad1 (Kretzschmar et al. 1997a).

[18] Smad1 is directly phosphorylated by the BMP receptor, resulting in Smad1 activation (Kretzschmar et al. 1997b), and by MAPK in response to EGF, resulting in Smad1 inhibition (Kretzschmar et al. 1997a; Fig. 2).

[19] Smad transcription factors mediate gene responses to the entire TGF (Transforming Growth Factor) family, to which the BMPs belong (for review, see Massague 2000; Derynck and Zhang 2003).

[20] Smads 1, 5, and 8 act primarily downstream of BMP receptors and Smads 2 and 3 downstream of TGF , Activin and Nodal receptors.

[21] Smad proteins have two conserved globular domains—the MH1 and MH2 domains (Fig. 2).

[22] The MH1 domain is involved in DNA binding and the MH2 domain in binding to cytoplasmic retention factors, activated receptors, nucleoporins in the nuclear pore, and DNA-binding cofactors, coactivators, and corepressors in the nucleus (for review, see Shi and Massague 2003).

[23] Receptor-mediated phosphorylation occurs at the carboxy-terminal sequence SXS.

[24] This enables the nuclear accumulation of Smads and their association with the shared partner Smad4 to form transcriptional complexes that are interpreted by the cell as a function of the context (Massague 2000).

[25] Between the MH1 and MH2 domains lies a linker region of variable sequence and length.

[26] Attention was drawn to this region when it was found that EGF (epidermal growth factor), a classical activator of the Ras/ MAPK pathway, causes phosphorylation of the Smad1 linker at four MAPK sites (PXSP sequences; Kretzschmar et al. 1997a).

[27] This prevents the nuclear localization of Smad1 and inhibits BMP signaling.

[28] Mutation of these E-MAIL j-massague@ski.mskcc.org; FAX (212) 717-3298.

[29] Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/ gad.1167003.

#### 文档 5700349：Mechanical coupling between transsynaptic N-cadherin adhesions and actin flow stabilizes dendritic spines

[0] The morphology of neuronal dendritic spines is a critical indicator of synaptic function.

[1] It is regulated by several factors, including the intracellular actin/myosin cytoskeleton and transcellular N-cadherin adhesions.

[2] To examine the mechanical relationship between these molecular components, we performed quantitative live-imaging experiments in primary hippocampal neurons.

[3] We found that actin turnover and structural motility were lower in dendritic spines than in immature filopodia and increased upon expression of a nonadhesive N-cadherin mutant, resulting in an inverse relationship between spine motility and actin enrichment.

[4] Furthermore, the pharmacological stimulation of myosin II induced the rearward motion of actin structures in spines, showing that myosin II exerts tension on the actin network.

[5] Strikingly, the formation of stable, spine-like structures enriched in actin was induced at contacts between dendritic filopodia and N-cadherin-coated beads or micropatterns.

[6] Finally, computer simulations of actin dynamics mimicked various experimental conditions, pointing to the actin flow rate as an important parameter controlling actin enrichment in dendritic spines.

[7] Together these data demonstrate that a clutch-like mechanism between N-cadherin adhesions and the actin flow underlies the stabilization of dendritic filopodia into mature spines, a mechanism that may have important implications in synapse initiation, maturation, and plasticity in the developing brain.

人工核对记录：

- 引用是否支持模型结论：UNREVIEWED
- 是否存在疑似标注问题：UNREVIEWED
- 错误类型：UNREVIEWED
- 判断理由：

